
HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPZVJ3ajBSSlFGazdSLXAydHFsbkx1QnJCeGIxYWU4N2xmTlIyQ0JUVDEtRVJrZG14NDhCTmx1OWJOWTJRQlZVeWRwUzNfOGxHNWpxeUNzdVpRV2FkZU13TkJXZE5wUk1qZHQ5WGs3dG5NTnBtZnNxVF85YVZTc1U3NzhmUEJKcFVQU0R0dVNUd0s1QQ?oc=5" target="_blank">HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>